anonymous
Guest
anonymous
Guest
Wondering when their payment to doctors for using their lab will come back to haunt them. Sleazy!
Heard this is continuing. Some reps are going to go to jail over this!Wondering when their payment to doctors for using their lab will come back to haunt them. Sleazy!
Look at Boston Heart situation, doctors are going to jail over payments.Heard this is continuing. Some reps are going to go to jail over this!
Wondering when their payment to doctors for using their lab will come back to haunt them. Sleazy!
Isn't paying over market value for a "lease" agreement the same as paying doctors directly? OIG thinks so!!! Look at GenPath, they're doing away with all of those lease agreements because they're scared. We should be scared too!They never did such a thing. You must be getting them confused with Bio Reference.
Isn't paying over market value for a "lease" agreement the same as paying doctors directly? OIG thinks so!!! Look at GenPath, they're doing away with all of those lease agreements because they're scared. We should be scared too!
Isn't paying over market value for a "lease" agreement the same as paying doctors directly? OIG thinks so!!! Look at GenPath, they're doing away with all of those lease agreements because they're scared. We should be scared too!
But client billing under Medicare rates will eventually get them. Sounds like a broken record, lab gets infused with VC money, needs to turn a profit and immediately goes for low client bill rates. Aurora was the latest to try this and failed. Q/L continue to do this but they succeed because they are the WalMart of labs. CPL tries but doesn't have the insurance coverage to make it profitable....o wait, neither does PathGroup, this should be interesting when someone starts looking at the profitablity of their clients.The key is utilizing certified local appraisers when fmv is determined. PathGroup will be in the clear.
Just because some other lab tried it and failed doesn't mean we will fail too. You probably don't even work here or now who we are!But client billing under Medicare rates will eventually get them. Sounds like a broken record, lab gets infused with VC money, needs to turn a profit and immediately goes for low client bill rates. Aurora was the latest to try this and failed. Q/L continue to do this but they succeed because they are the WalMart of labs. CPL tries but doesn't have the insurance coverage to make it profitable....o wait, neither does PathGroup, this should be interesting when someone starts looking at the profitablity of their clients.
Great "key", wink wink, cough cough. When the doctor wants more we give in to them.The key is utilizing certified local appraisers when fmv is determined. PathGroup will be in the clear.
I was in an officce the other day and they asked me how our client bill rates were lower than Q and L. I made up an answer, but how is it that we can offer pricing lower than the walmarts of the lab industry?Offering client bill rates of 90% below medicare rates won't get us in trouble, right?
why ask stupid questions on a forum?I was in an officce the other day and they asked me how our client bill rates were lower than Q and L. I made up an answer, but how is it that we can offer pricing lower than the walmarts of the lab industry?